Bone Marrow-Specific Deficiency of Nuclear Receptor Nur77 Enhances Atherosclerosis

Bone Marrow-Specific Deficiency of Nuclear Receptor Nur77 Enhances Atherosclerosis
复制标题

DOI:
10.1161/circresaha.111.260760
复制
发表时间:
2012-02-03
影响因子:
20.1
通讯作者:
de Vries, Carlie J. M.
de Vries, Carlie J. M.
中科院分区:
医学1区
文献类型:
--
作者:
Hamers, Anouk A. J.;Vos, Mariska;de Vries, Carlie J. M.

文献摘要

被引文献

相似文献

基本原理:核受体Nur 77,也称为NR 4A 1、TR 3或NGFI-B,在巨噬细胞、内皮细胞、T细胞和平滑肌细胞中的人类动脉粥样硬化病变中表达。巨噬细胞Nur 77在动脉粥样硬化中起着重要作用,而Nur 77在病变巨噬细胞中的功能尚未被研究。目的:本研究旨在阐明Nur 77在巨噬细胞中的功能,并评估骨髓特异性Nur 77缺陷对动脉粥样硬化的影响。我们使用来自野生型和Nur 77敲除(Nur 77(-/-))小鼠的骨髓源性巨噬细胞(BMM)研究了Nur 77在巨噬细胞极化中的作用。Nur 77(-/-)BMM表现出M2特异性标志物的表达改变和炎性M1表型,在(未)刺激的Nur 77(-/-)BMM细胞中,白细胞介素-12、IFN γ和SDF-1 α的表达增强,NO合成增加。在未刺激的Nur 77(-/-)BMM中,SDF-1 α表达被Nur 77抑制,并且Nur 77(-/-)BMM的化学吸引活性被SDF-1 α抑制抗体消除。此外,Nur 77(-/-)小鼠显示巯基乙酸盐引起的巨噬细胞和B细胞迁移增强。在低密度脂蛋白受体缺陷(Ldlr(-/-))小鼠中研究了骨髓特异性Nur 77缺陷对动脉粥样硬化的影响。Nur 77(-/-)缺陷骨髓移植的Ldlr(-/-)小鼠比野生型骨髓移植小鼠发生2.1倍大的动脉粥样硬化病变。这些病变含有更多的巨噬细胞、T细胞、平滑肌细胞和更大的坏死核心。SDF-1 α的表达是较高的病变的Nur 77(-/-)-移植小鼠,这可以解释所观察到的恶化的病变formation.Conclusions:总之,在骨髓来源的细胞的核受体Nur 77具有抗炎功能,抑制SDF-1 α的表达和抑制动脉粥样硬化。(Circ Res. 2012;110:428-438)。
Rationale: Nuclear receptor Nur77, also known as NR4A1, TR3, or NGFI-B, is expressed in human atherosclerotic lesions in macrophages, endothelial cells, T cells and smooth muscle cells. Macrophages play a critical role in atherosclerosis and the function of Nur77 in lesion macrophages has not yet been investigated.Objective: This study aims to delineate the function of Nur77 in macrophages and to assess the effect of bone marrow-specific deficiency of Nur77 on atherosclerosis.Methods and Results: We investigated Nur77 in macrophage polarization using bone marrow-derived macrophages (BMM) from wild-type and Nur77-knockout (Nur77(-/-))mice. Nur77(-/-) BMM exhibit changed expression of M2-specific markers and an inflammatory M1-phenotype with enhanced expression of interleukin-12, IFN gamma, and SDF-1 alpha and increased NO synthesis in (non)-stimulated Nur77(-/-) BMM cells. SDF-1 alpha expression in nonstimulated Nur77(-/-) BMM is repressed by Nur77 and the chemoattractive activity of Nur77(-/-) BMM is abolished by SDF-1 alpha inhibiting antibodies. Furthermore, Nur77(-/-) mice show enhanced thioglycollate-elicited migration of macrophages and B cells. The effect of bone marrow-specific deficiency of Nur77 on atherosclerosis was studied in low density lipoprotein receptor-deficient (Ldlr(-/-)) mice. Ldlr(-/-) mice with a Nur77(-/-)-deficient bone marrow transplant developed 2.1-fold larger atherosclerotic lesions than wild-type bone marrow-transplanted mice. These lesions contain more macrophages, T cells, smooth muscle cells and larger necrotic cores. SDF-1 alpha expression is higher in lesions of Nur77(-/-)-transplanted mice, which may explain the observed aggravation of lesion formation.Conclusions: In conclusion, in bone marrow-derived cells the nuclear receptor Nur77 has an anti-inflammatory function, represses SDF-1 alpha expression and inhibits atherosclerosis. (Circ Res. 2012;110:428-438.)